Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $359.11 | 18 | 78.2% |
| Education | $99.99 | 1 | 21.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $99.99 | 1 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $74.37 | 4 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $73.88 | 1 | $0 (2022) |
| GlaxoSmithKline, LLC. | $31.89 | 2 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $28.59 | 2 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $24.29 | 1 | $0 (2024) |
| Lilly USA, LLC | $21.16 | 1 | $0 (2024) |
| Amgen Inc. | $18.27 | 1 | $0 (2018) |
| Gilead Sciences, Inc. | $15.69 | 1 | $0 (2024) |
| PUMA BIOTECHNOLOGY, INC. | $15.61 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $212.98 | 12 | E.R. Squibb & Sons, L.L.C. ($74.37) |
| 2022 | $73.88 | 1 | AstraZeneca Pharmaceuticals LP ($73.88) |
| 2019 | $13.20 | 1 | Incyte Corporation ($13.20) |
| 2018 | $159.04 | 5 | Alexion Pharmaceuticals, Inc. ($99.99) |
All Payment Transactions
19 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: ONCOLOGY | ||||||
| 12/10/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.69 | General |
| 11/18/2024 | E.R. Squibb & Sons, L.L.C. | KRAZATI (Drug) | Food and Beverage | Cash or cash equivalent | $17.05 | General |
| Category: Oncology | ||||||
| 11/12/2024 | Lilly USA, LLC | VERZENIO (Drug), JAYPIRCA | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: Oncology | ||||||
| 10/21/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: ONCOLOGY | ||||||
| 10/16/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: Oncology | ||||||
| 10/15/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $24.29 | General |
| Category: ONCOLOGY | ||||||
| 09/18/2024 | E.R. Squibb & Sons, L.L.C. | KRAZATI (Drug) | Food and Beverage | Cash or cash equivalent | $17.65 | General |
| Category: Oncology | ||||||
| 08/21/2024 | Astellas Pharma US Inc | Padcev (Drug) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: Oncology | ||||||
| 07/31/2024 | E.R. Squibb & Sons, L.L.C. | KRAZATI (Drug) | Food and Beverage | Cash or cash equivalent | $17.84 | General |
| Category: Oncology | ||||||
| 06/05/2024 | E.R. Squibb & Sons, L.L.C. | KRAZATI (Drug) | Food and Beverage | Cash or cash equivalent | $21.83 | General |
| Category: Oncology | ||||||
| 05/22/2024 | PUMA BIOTECHNOLOGY, INC. | — | Food and Beverage | In-kind items and services | $15.61 | General |
| 07/20/2022 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $73.88 | General |
| Category: Oncology | ||||||
| 10/17/2019 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $13.20 | General |
| Category: Hematology/Oncology | ||||||
| 11/14/2018 | Celgene Corporation | Revlimid (Drug) | Food and Beverage | In-kind items and services | $12.74 | General |
| Category: Hematology / Oncology | ||||||
| 10/16/2018 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: Immunology | ||||||
| 08/28/2018 | Amgen Inc. | Kyprolis (Biological), XGEVA | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: Oncology | ||||||
| 08/09/2018 | Novartis Pharmaceuticals Corporation | RYDAPT (Drug), TASIGNA | Food and Beverage | In-kind items and services | $12.90 | General |
| Category: HEMATOLOGY | ||||||
| 07/26/2018 | Bayer HealthCare Pharmaceuticals Inc. | Stivarga (Drug), Nexavar | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 127 | 230 | $67,371 | $15,101 |
| 2022 | 2 | 31 | 39 | $18,044 | $4,557 |
| 2021 | 2 | 29 | 37 | $18,839 | $2,612 |
| 2020 | 2 | 39 | 57 | $32,870 | $3,439 |
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 86 | 165 | $40,789 | $8,162 | 20.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 19 | 43 | $13,631 | $3,969 | 29.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 22 | 22 | $12,951 | $2,970 | 22.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 19 | 19 | $11,704 | $2,949 | 25.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 12 | 20 | $6,340 | $1,609 | 25.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 17 | 23 | $11,956 | $1,847 | 15.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 12 | 14 | $6,883 | $764.61 | 11.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 28 | 41 | $21,012 | $2,178 | 10.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 11 | 16 | $11,858 | $1,261 | 10.6% |
About Dr. Nwabundo Anusim, M.D
Dr. Nwabundo Anusim, M.D is a Hematology & Oncology healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/05/2011. The National Provider Identifier (NPI) number assigned to this provider is 1144504408.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nwabundo Anusim, M.D has received a total of $459.10 in payments from pharmaceutical and medical device companies, with $212.98 received in 2024. These payments were reported across 19 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($359.11).
As a Medicare-enrolled provider, Anusim has provided services to 226 Medicare beneficiaries, totaling 363 services with total Medicare billing of $25,710. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Location Austin, TX
- Active Since 10/05/2011
- Last Updated 01/21/2026
- Taxonomy Code 207RH0003X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1144504408
Products in Payments
- SOLIRIS (Drug) $99.99
- KRAZATI (Drug) $74.37
- CALQUENCE (Drug) $73.88
- OJJAARA (Drug) $31.89
- LIBTAYO (Biological) $24.29
- VERZENIO (Drug) $21.16
- Kyprolis (Biological) $18.27
- KISQALI (Drug) $15.69
- Stivarga (Drug) $15.14
- Padcev (Drug) $14.28
- JAKAFI (Drug) $13.20
- RYDAPT (Drug) $12.90
- Revlimid (Drug) $12.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Austin
Dr. Debra Patt, Md, Mph, MD, MPH
Hematology & Oncology — Payments: $109,909
Uttam Rao
Hematology & Oncology — Payments: $19,966
Dr. Allison Gorrebeeck, Md, MD
Hematology & Oncology — Payments: $5,624
Dr. Richard Helmer, M.d, M.D
Hematology & Oncology — Payments: $3,540
Vinod Kondragunta
Hematology & Oncology — Payments: $3,490
Dr. Shubhada Shrikhande, Md, MD
Hematology & Oncology — Payments: $1,469